Tuesday, September 29, 2026Austin, TexasVol. 1

The people, science and technologies redefining human health.

The Signal

An FDA panel backed the first multi-cancer blood test. Here's what the data actually show.

Advisers voted 7–2 that Galleri's benefits outweigh its risks. The FDA's own briefing shows a test that is very specific, finds about a third of cancers within a year, and raises questions nobody has answered yet.

Sep 29, 2026 · Diagnostics

Texas Health Atlas

All 14 companies →

A sourced directory of Texas health-innovation companies, with what they build and where each stands with regulators. Every entry links its sources and a review date.

GenprexAustin · BiotechnologyClinical-stage gene therapy company developing therapies for cancer and diabetes.XBiotechAustin · BiotechnologyDiscovers and develops therapeutic antibodies derived from natural human immunity (its True Human antibodies), with candidates across oncology, neurology, rheumatology and infectious disease.NateraAustin · Diagnostics, BiotechnologyCell-free DNA (cfDNA) testing company working in oncology, women's health and organ health.EverlywellAustin · Digital health, DiagnosticsAt-home lab testing: customers collect samples at home, partner labs run the tests and a physician reviews results.WheelAustin · Digital healthInfrastructure for companies that want to offer virtual care under their own brand, paired with a nationwide clinician network.Alleviant MedicalAustin · MedTechDeveloping a no-implant interatrial shunt for heart failure: a single procedure creates a connection between the heart's upper chambers without leaving a permanent implant.

Topics

All topics →
DiagnosticsMedTechBiotechnologyAI in healthcareEvidence & claimsDigital health

Future Health Weekly

One breakthrough, one company to watch, one person to know, the signal, Texas and what's coming up. High signal, low fluff.

You're subscribed. The next issue is on its way.